share_log

DEF 14A: Definitive information statements

DEF 14A: Definitive information statements

DEF 14A：股東委託書決議
美股sec公告 ·  05/31 02:18
牛牛AI助理已提取核心訊息
60 Degrees Pharmaceuticals, Inc. (60P) has announced a series of significant corporate events, including the approval of a reverse stock split, amendments to equity incentive plans, and the ratification of RBSM LLP as their independent auditor for the fiscal year ending December 31, 2024. The reverse stock split, at a ratio ranging from 1:5 to 1:12, is intended to raise the per-share trading price of 60P's common stock to comply with Nasdaq listing requirements. Additionally, the company seeks shareholder approval to increase the number of shares authorized under its 2022 Equity Incentive Plan by 5,000,000 shares. Amendments to the strike price and vesting provisions of options granted to the CEO and CFO, as well as the issuance of options to a consultant, are also subject to shareholder...Show More
60 Degrees Pharmaceuticals, Inc. (60P) has announced a series of significant corporate events, including the approval of a reverse stock split, amendments to equity incentive plans, and the ratification of RBSM LLP as their independent auditor for the fiscal year ending December 31, 2024. The reverse stock split, at a ratio ranging from 1:5 to 1:12, is intended to raise the per-share trading price of 60P's common stock to comply with Nasdaq listing requirements. Additionally, the company seeks shareholder approval to increase the number of shares authorized under its 2022 Equity Incentive Plan by 5,000,000 shares. Amendments to the strike price and vesting provisions of options granted to the CEO and CFO, as well as the issuance of options to a consultant, are also subject to shareholder approval to comply with Nasdaq Listing Rule 5635(c). The company's board has the discretion to determine the timing and ratio of the reverse stock split and may abandon the plan before it becomes effective. The annual meeting of stockholders, where these proposals will be considered, is scheduled for July 16, 2024, and will be held virtually via audio webcast.
60 Degrees Pharmicals, Inc.（60P）宣佈了一系列重大公司活動，包括批准反向股票拆分、修訂股權激勵計劃以及批准RBSM LLP作爲截至2024年12月31日的財年的獨立核數師。反向股票拆分的比率從 1:5 到 1:12 不等，旨在提高60便士普通股的每股交易價格，以符合納斯達克的上市要求。此外，該公司尋求股東批准，將其2022年股權激勵計劃授權的股票數量增加5,000,000股。對授予首席執行官和首席財務官的期權的行使價和歸屬條款的修訂，以及向顧問發行期權，也需要獲得股東批准，以遵守納斯達克上市規則5635（c）。公司董事會有權決定反向股票拆分的時間和比例，並可能在計劃生效之前放棄該計劃。年度股東大會定於2024年7月16日舉行，將通過網絡音頻直播虛擬舉行，屆時將審議這些提案。
60 Degrees Pharmicals, Inc.（60P）宣佈了一系列重大公司活動，包括批准反向股票拆分、修訂股權激勵計劃以及批准RBSM LLP作爲截至2024年12月31日的財年的獨立核數師。反向股票拆分的比率從 1:5 到 1:12 不等，旨在提高60便士普通股的每股交易價格，以符合納斯達克的上市要求。此外，該公司尋求股東批准，將其2022年股權激勵計劃授權的股票數量增加5,000,000股。對授予首席執行官和首席財務官的期權的行使價和歸屬條款的修訂，以及向顧問發行期權，也需要獲得股東批准，以遵守納斯達克上市規則5635（c）。公司董事會有權決定反向股票拆分的時間和比例，並可能在計劃生效之前放棄該計劃。年度股東大會定於2024年7月16日舉行，將通過網絡音頻直播虛擬舉行，屆時將審議這些提案。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。